Drug · DIN 02393468
APO-RIZATRIPTAN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 6, 2013; first marketed March 6, 2013.
- Drug Identification Number (DIN)
- 02393468
- Company (DIN owner)
- Apotex Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Rizatriptan N02CC04
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RIZATRIPTAN (RIZATRIPTAN BENZOATE) | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 27, 2012: NOC 13692Abbreviated New Drug Submission (ANDS)
Other DINs named APO-RIZATRIPTAN
- DIN 02393476 · Marketed